Stocktoria
SANUWAVE Health, Inc. SNWV
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2008-11-07
SANUWAVE Health, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $44.1M | $32.6M | $20.4M | $16.7M | $13.0M |
| Gross profit | $34.0M | $24.6M | $14.4M | $12.4M | $8.0M |
| R&D expense | $1.4M | $673,000 | $579,000 | $567,000 | $1.1M |
| Operating income | $4.9M | $3.8M | -$540,000 | -$9.0M | -$14.1M |
| Income tax | $86,000 | $27,000 | $4,000 | $2,000 | $28,000 |
| Net income | $11.8M | -$33.1M | -$25.8M | -$10.3M | -$27.3M |
| EPS (diluted) | $0.41 | $-7.41 | $-12.19 | $-0.02 | $-0.05 |
| Operating cash flow | $3.9M | $2.5M | -$4.5M | -$17.2M | -$6.4M |
| Free cash flow | $1.9M | $2.0M | -$4.5M | — | -$6.9M |
| Cash & equivalents | $12.0M | $10.2M | $1.8M | $1.2M | $619,000 |
| Inventory | $5.9M | $4.1M | $3.0M | $868,000 | $1.0M |
| Total assets | $37.3M | $30.1M | $22.4M | $19.9M | $18.6M |
| Total liabilities | $35.7M | $45.9M | $65.6M | $60.9M | $57.6M |
| Shareholders' equity | $1.6M | -$15.8M | -$44.5M | -$41.0M | -$39.0M |
Source: SEC EDGAR filings · CIK 0001417663 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.